Jahrling P B, Stephenson E H
J Clin Microbiol. 1984 Mar;19(3):429-31. doi: 10.1128/jcm.19.3.429-431.1984.
Although two investigational vaccines are used to immunize humans against Venezuelan equine encephalomyelitis virus, neither had previously been tested for protective efficacy against aerosol exposure. Live attenuated vaccine (TC-83) protected all hamsters challenged by either aerosol or subcutaneous routes with 4.7 to 5.2 log10 PFU of virulent Venezuelan equine encephalomyelitis virus. Formaldehyde-inactivated vaccine (C-84) failed to protect against aerosol challenge but did protect against subcutaneous challenge. Protection elicited by TC-83 vaccine did not depend solely on serum-neutralizing antibody. These studies suggest that TC-83 vaccine is preferable to C-84 vaccine for protecting laboratory workers at risk to aerosol exposure.
虽然有两种研究性疫苗用于人类免疫以抵抗委内瑞拉马脑炎病毒,但此前均未针对气溶胶暴露的保护效力进行过测试。减毒活疫苗(TC-83)可保护所有通过气溶胶或皮下途径用4.7至5.2 log10 PFU强毒委内瑞拉马脑炎病毒攻击的仓鼠。甲醛灭活疫苗(C-84)未能预防气溶胶攻击,但可预防皮下攻击。TC-83疫苗引发的保护作用并非仅取决于血清中和抗体。这些研究表明,对于有气溶胶暴露风险的实验室工作人员,TC-83疫苗比C-84疫苗更可取。